We are live on ! Find out more
PBHC icon

Pathfinder Bancorp

20 hedge funds and large institutions have $17.5M invested in Pathfinder Bancorp in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $14.4M → $17.5M (+$3.15M)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

0.87% less ownership

Funds ownership: 18.46%17.59% (-0.87%)

5% less funds holding

Funds holding: 2120 (-1)

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
5
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change

PBHC Hedge Fund Activity: Q1 2022 in Review

20 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Pathfinder Bancorp (PBHC) for Q1 2022, worth a combined $17.5M — up 22% from $14.4M a quarter earlier.

Fund positioning in PBHC was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 5 trimmed.

The largest buyer was Basswood Capital Management, adding an estimated $1.39M. The largest seller was Rockbridge Investment Management, cutting an estimated $2.36M.

  • 20 institutional investors held Pathfinder Bancorp (PBHC) as of Q1 2022, down from 21 in Q4 2021.
  • Funds reported $17.5M of Pathfinder Bancorp stock for Q1 2022, up 22% quarter-over-quarter.
  • 3 funds opened new Pathfinder Bancorp positions in Q1 2022 and 3 closed out, a net change of 0 holders.
  • The largest Pathfinder Bancorp buyer in Q1 2022 was Basswood Capital Management, an estimated $1.39M added.
  • The largest Pathfinder Bancorp seller in Q1 2022 was Rockbridge Investment Management, an estimated $2.36M sold.

Based on aggregated 13F filings for Q1 2022.